Changing landscape of steatotic liver diseases and liver fibrosis in the United States during the COVID-19 pandemic
Our study highlights a shift in SLDs in the United States during the COVID-19 pandemic, showing a decrease in MASLD and increases in MetALD and ALD, with an alarming increase in the prevalence of CSF, likely reflecting lifestyle changes, including physical inactivity and alcohol consumption.
Authors
- Abdelrahman M. Attia (ORCID: https://orcid.org/0000-0002-5941-9717)
- Yee Hui Yeo (ORCID: https://orcid.org/0000-0002-2703-5954)
- Soo Young Hwang (ORCID: https://orcid.org/0000-0001-9845-7073)
- Min‐Sun Kwak (ORCID: https://orcid.org/0000-0003-0353-6460)
- Mohammad Saeid Rezaee‐Zavareh (ORCID: https://orcid.org/0000-0003-0447-6607)
- Hyun‐Seok Kim (ORCID: https://orcid.org/0000-0002-5580-2532)
- Mazen Noureddin
Institutions
- Cedars-Sinai Medical Center (US)
- Houston Methodist (US)
- Seoul National University Hospital (KR)
- Methodist Hospital (US)
- Middle East Liver Disease Center (IR)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1097/hc9.0000000000000806
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.71